TickerFiles

Autolus Therapeutics plc 10-Q filing

Filed 2025-08-12 · Report date 2025-06-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001730463-25-000067
Form type
10-Q
CIK
0001730463
Primary document
https://www.sec.gov/Archives/edgar/data/1730463/000173046325000067/autl-20250630.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Autolus Therapeutics plc.

Reported financial metrics

MetricCurrentPriorChange
Revenue$29.9M--
Cost Of Revenue$42.4M--
Operating Income$-126.5M--
Net Income$-118.1M--
Eps Basic-0.44--
Eps Diluted-0.44--
Cash And Equivalents$123.8M--
Total Assets$721.0M--
Total Liabilities$374.5M--
Shareholders Equity$346.5M--
Operating Cash Flow$-148.3M--
Capital Expenditures$15.5M--